Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer

Ample attention has focused on cancer drug delivery via prodrug nanoparticles due to their high drug loading property and comparatively lower side effects. In this study, we designed a PEG-DOX-Cur prodrug nanoparticle for simultaneous delivery of doxorubicin (DOX) and curcumin (Cur) as a combination...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Zhang, Yumin, Yang, Cuihong, Wang, Weiwei, Liu, Jinjian, Liu, Qiang, Huang, Fan, Chu, Liping, Gao, Honglin, Li, Chen, Kong, Deling, Liu, Qian, Liu, Jianfeng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4753416/
https://ncbi.nlm.nih.gov/pubmed/26876480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep21225
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia